These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


212 related items for PubMed ID: 8643199

  • 1. Effect of recombinant human erythropoietin on soluble interleukin 2 receptor (SIL-2R) levels in haemodialysis patients.
    Altun B, Erdem Y, Haznedaroğlu I, Gürsoy M, Yasavul U, Turgan C, Cağlar S, Kirazli S.
    Nephrol Dial Transplant; 1995 Nov; 10(11):2164. PubMed ID: 8643199
    [No Abstract] [Full Text] [Related]

  • 2. Human recombinant erythropoietin (rHuEPO) in the treatment of anemia in patients with chronic renal failure (CRF): experience with a group of patients on chronic haemodialysis treatment.
    Ramírez B, Flores A, Pérez F, Córdoba C, García L, Vázquez G.
    Transplant Proc; 1991 Apr; 23(2):1833-4. PubMed ID: 2053170
    [No Abstract] [Full Text] [Related]

  • 3. Use of recombinant erythropoietin in the treatment of anaemia associated with multiple myeloma in a haemodialysis patient.
    Hussein MM, Mooij JM, Roujouleh H.
    Nephrol Dial Transplant; 1994 Apr; 9(7):876-7. PubMed ID: 7818713
    [No Abstract] [Full Text] [Related]

  • 4. Serum soluble interleukin 2 receptor in hemodialysis patients treated with recombinant human erythropoietin.
    Sennesael JJ, Demanet CG, Verbeelen DL.
    Blood Purif; 1995 Apr; 13(6):347-56. PubMed ID: 8821199
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of the anaemia of end-stage renal disease with recombinant human erythropoietin.
    Verbeelen D, Hauglustaine D, Sennesael J.
    Neth J Med; 1988 Aug; 33(1-2):60-7. PubMed ID: 3247012
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Quality of life in end-stage renal disease patients during recombinant human erythropoietin therapy. The Canadian Erythropoietin Study Group.
    Keown PA.
    Contrib Nephrol; 1991 Aug; 88():81-6; discussion 87-9. PubMed ID: 2040199
    [No Abstract] [Full Text] [Related]

  • 14. Blood rheology in hemodialysis patients treated with recombinant human erythropoietin.
    Brunner R, Pollok M, Heidel M, Müller R, Degenhardt S, Baldamus CA.
    Contrib Nephrol; 1989 Aug; 76():306-12; discussion 312-4. PubMed ID: 2582784
    [No Abstract] [Full Text] [Related]

  • 15. Does correction of anemia with recombinant human erythropoietin accelerate the progression of renal insufficiency?
    Lim VS.
    Semin Nephrol; 1990 Mar; 10(2 Suppl 1):26-7. PubMed ID: 2356366
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Is the index of response to erythropoietin (IRE) a good marker of adequate dialysis?].
    Pérez-García R, Rodríguez-Benítez P, Villaverde MT, Valderrábano F.
    Nefrologia; 2001 Mar; 21(6):606-7. PubMed ID: 11881433
    [No Abstract] [Full Text] [Related]

  • 19. [Low doses of recombinant erythropoietin in the treatment of renal anemia in patients on chronic hemodialysis and ambulatory peritoneal dialysis].
    Lashutin SV, Nikolaev AIu, Ermolenko VM, Shutov EV, Bezruk VG, Ivashchenko MA.
    Ter Arkh; 1999 Mar; 71(6):61-3. PubMed ID: 10420460
    [Abstract] [Full Text] [Related]

  • 20. Changes in quality of life and functional capacity in hemodialysis patients treated with recombinant human erythropoietin. The Canadian Erythropoietin Study Group.
    Laupacis A.
    Semin Nephrol; 1990 Mar; 10(2 Suppl 1):11-9. PubMed ID: 2192412
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.